It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2006.
2006 | Mumbai, Maharashtra, India | Struck OffRns Pharmaceuticals Pvt Ltd, a struck off private limited company, was established on 23 August 2006 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U51397MH2006PTC163984. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Vasant Ganpat Chavan (Director), Mukesh Harkishandas Chitalia (Director), Mohan Ganpat Chavan (Director). It holds no open charges and ₹2.00 Cr settled loans. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at Shop No. 10, Girnar Bldg, 69 Tardeo Road Tardeo, Mumbai, Maharashtra, 400034.
U51397MH2006PTC163984
163984
23 August 2006
₹1.00 M
₹1.00 M
Roc Mumbai
Unlisted
Struck Off
Explore comprehensive insights into Rns Pharmaceuticals Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vasant Ganpat Chavan | Director | 23 Aug 2006 | Current |
| Mukesh Harkishandas Chitalia | Director | 23 Aug 2006 | Current |
| Mohan Ganpat Chavan | Director | 23 Aug 2006 | Current |
| Ankit Pankaj Parekh | Director | 23 Aug 2006 | Current |
| Binoy Pankaj Parekh | Director | 23 Aug 2006 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rns Pharmaceuticals Pvt Ltd, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 58.94% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
In 2021, Rns Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹20,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Nov 2014 | Axis Bank Limited | ₹1.00 Cr | Satisfied |
| 27 Sep 2014 | Axis Bank Limited | ₹1.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Rns Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rns Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rns Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 17 Nov 2014 via Charge ID 10535623 with Axis Bank Limited was fully satisfied on 19 Apr 2022. was completed.
Progress on A charge registered on 27 Sep 2014 via Charge ID 10525964 with Axis Bank Limited was fully satisfied on 19 Apr 2022. was documented.
Rns Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was recorded as a recent event.
Progress on Rns Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Mumbai. was documented.
The activity A charge with Axis Bank Limited amounted to Rs. 10.00 M with Charge ID 10535623 was registered on 17 Nov 2014. was completed.
A charge with Axis Bank Limited amounted to Rs. 10.00 M with Charge ID 10525964 was registered on 27 Sep 2014. was recorded as a recent event.
The CIN of Rns Pharmaceuticals Pvt Ltd is U51397MH2006PTC163984.
Rns Pharmaceuticals Pvt Ltd is headquartered at Shop No. 10, Girnar Bldg, 69 Tardeo Road Tardeo, Mumbai, Maharashtra, 400034.
Rns Pharmaceuticals Pvt Ltd was incorporated on 23 August 2006.
The current directors of Rns Pharmaceuticals Pvt Ltd are
The primary industry of Rns Pharmaceuticals Pvt Ltd is Manufacturing.
Rns Pharmaceuticals Pvt Ltd is unlisted.
The authorized capital of Rns Pharmaceuticals Pvt Ltd is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Rns Pharmaceuticals Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX